remission of multiple myeloma with car t-cell therapy
Published 8 years ago • 721 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
0:48
selecting patients with multiple myeloma for car-t therapy
-
4:04
overcoming challenges in car t-cell therapy for multiple myeloma
-
2:00
the value of car-t cell therapy for the treatment of r/r multiple myeloma
-
2:40
car t-cell therapy to revolutionize multiple myeloma?
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
4:04
the future of myeloma treatment and the possibility of cure
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
3:03
the future of car-t therapy for multiple myeloma
-
1:21
developing off-the-shelf car t-cells to treat multiple myeloma
-
0:50
car-t in multiple myeloma: cilta-cel & ide-cel
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
2:14
bms-986393 car t-cell therapy for r/r multiple myeloma: results of a phase i trial
-
5:11
phase i study of phe885 car t-cell therapy in r/r multiple myeloma
-
1:23
managing patients with multiple myeloma who have stopped treatment prior to relapse
-
4:14
car t-cell therapy for refractory multiple myeloma
-
9:48
the use of car t-cells in multiple myeloma
-
0:46
challenges associated with the use of off-the-shelf car-t products in multiple myeloma
-
3:27
car-t cells in myeloma
-
4:14
challenges with the real-world use of car-t therapy in multiple myeloma
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
4:12
car-t therapy in multiple myeloma: recent updates, clinical trials and future outlooks
-
1:38
how to optimize access to car-t cell therapies in multiple myeloma